Elevated cytokine and chemokine levels in the placenta are associated with in-utero HIV-1 mother-to-child transmission.

Authors:
Address: The Center for Microbial Interface Biology, College of Public Health, The Ohio State University, Columbus, USA.
Journal:


Publication:

abstract

OBJECTIVE:

To determine whether there is an association between cytokine and chemokine levels in plasma isolated from the placenta and HIV-1 mother-to-child transmission (MTCT).

DESIGN:

We designed a case-control study of HIV-infected, pregnant women enrolled in the Malaria and HIV in Pregnancy cohort. Participants were recruited in Blantyre, Malawi, from 2000 to 2004. Patients were women whose children were HIV-1 DNA-positive at birth (in-utero MTCT) or HIV-1 DNA-negative at birth and HIV-1 DNA-positive at 6 weeks postpartum (intrapartum MTCT); controls were women whose children were HIV-1 DNA-negative both at birth and 6 weeks postpartum.

METHODS:

After delivery, blood was isolated from an incision on the basal plate of the placenta. We used a Bio-Plex human cytokine assay (Bio-Rad, Hercules, California USA) to simultaneously quantify 27 cytokines, chemokines and growth factors in placental plasma. HIV-1 RNA copies were quantified with the Roche Amplicor kit.

RESULTS:

Levels of interleukin (IL) 4, IL-5, IL-6, IL-7, IL-9, eotaxin, IL-1Ra and interferon gamma-induced protein 10 (IP-10) were significantly Elevated in placental plasma isolated from cases of in-utero HIV-1 MTCT. In contrast, only granulocyte colony-stimulating factor was elevated in placental plasma isolated from cases of intrapartum MTCT. After adjusting for maternal age, gestational age and peripheral CD4(+) T-cell count, every log(10) increase in placental IP-10 was associated with a three-fold increase in the prevalence of in-utero HIV-1 MTCT.

CONCLUSION:

Elevated cytokine and chemokine levels in placental plasma were associated with in-utero and not intrapartum MTCT. IP-10, which is both a T-cell chemokine and potentiator of HIV-replication, was robustly and independently associated with prevalent, in-utero MTCT.



Related Articles
Maternal syphilis infection is associated with increased risk of mother-to-child transmission of HIV in Malawi.
AIDS. 2006
Maternal syphilis infection is associated with increased risk of mother-to-child transmission of HIV in Malawi.
Mwapasa V, Rogerson SJ, Kwiek JJ, Wilson PE, Milner D, Molyneux ME, Kamwendo DD, Tadesse E, Chaluluka E, Meshnick SR. AIDS. 2006 Sep 11; 20(14):1869-77.
Maternal-fetal microtransfusions and HIV-1 mother-to-child transmission in Malawi.
PLoS Med. 2006
Maternal-fetal microtransfusions and HIV-1 mother-to-child transmission in Malawi.
Kwiek JJ, Mwapasa V, Milner DA Jr, Alker AP, Miller WC, Tadesse E, Molyneux ME, Rogerson SJ, Meshnick SR. PLoS Med. 2006 Jan; 3(1):e10. Epub 2005 Nov 22.
Association of HIV and malaria with mother-to-child transmission, birth outcomes, and child mortality.
J Acquir Immune Defic Syndr. 2...
Association of HIV and malaria with mother-to-child transmission, birth outcomes, and child mortality.
Brahmbhatt H, Sullivan D, Kigozi G, Askin F, Wabwire-Mangenm F, Serwadda D, Sewankambo N, Wawer M, Gray R. J Acquir Immune Defic Syndr. 2008 Apr 1; 47(4):472-6.
Review Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Cochrane Database Syst Rev. 2010
Review Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS, Dokubo EK, Sint TT. Cochrane Database Syst Rev. 2010 Mar 17; (3):CD008440. Epub 2010 Mar 17.
Review Interventions for preventing late postnatal mother-to-child transmission of HIV.
Cochrane Database Syst Rev. 2009
Review Interventions for preventing late postnatal mother-to-child transmission of HIV.
Horvath T, Madi BC, Iuppa IM, Kennedy GE, Rutherford G, Read JS. Cochrane Database Syst Rev. 2009 Jan 21; (1):CD006734. Epub 2009 Jan 21.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.